Review

Nature Reviews Neuroscience 7, 860-872 (November 2006) | doi:10.1038/nrn2007

Macular degeneration: recent advances and therapeutic opportunities

Amir Rattner1 & Jeremy Nathans1,2  About the authors

Top

The central retina mediates high acuity vision, and its progressive dysfunction due to macular degeneration is the leading cause of visual disability among adults in industrialized societies. Here, we summarize recent progress in understanding the pathophysiology of macular degeneration and the implications of this new knowledge for treatment and prevention. The past decade has witnessed remarkable advances in this field, including the development of new, non-invasive retinal imaging technologies, the development of animal models for macular disease, and the isolation of many of the genes responsible for both early- and late-onset macular diseases. These advances have set the stage for the development of effective mechanism-based therapies.

Author affiliations

  1. Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
  2. Department of Neuroscience, Department of Ophthalmology, and the Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Correspondence to: Jeremy Nathans1,2 Email: jnathans@jhmi.edu

Published online 11 October 2006

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

The ABCs of AMD

Nature Medicine News and Views (01 Nov 1997)

Macrophages eyed in macular degeneration

Nature Medicine News and Views (01 Nov 2003)

See all 4 matches for News And Views

Extra navigation

Subscribe

Subscribe to Nature Reviews Neuroscience

Search PubMed for

Open Innovation Challenges

naturejobs

natureproducts


Advertisement